Phase II Trial of Sequential Gefitinib After Minor Response or Partial Response to Chemotherapy in Chinese Patients With Advanced Non-Small-Cell Lung Cancer

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-6-288
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Circulating Nucleosomes Predict the Response to Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2016English

Correlation Between KRAS Mutation Status and Response to Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer☆

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2016English

Phase I Trial of Sorafenib in Combination With Gefitinib in Patients With Refractory or Recurrent Non Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

Management of Patients With Advanced Non-Small Cell Lung Cancer: Role of Gefitinib

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2010English

Phase II Study of Docetaxel Alternating With Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2000English

Clinical Response to Chemotherapy in Non-Small Cell Lung Carcinoma Patients

International Journal of Research in Medical Sciences
2019English

Chemotherapy-Induced Epidermal Growth Factor Receptor Activation Determines Response to Combined Gefitinib/Chemotherapy Treatment in Non-Small Cell Lung Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Phase I/Ii Study of Gefitinib (Iressa®) and Vorinostat (IVORI) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy